The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
Pharmaceutical Technology discusses the key issues and trends facing the pharmaceutical supply chain with Bob Kanuga, executive director of the external manufacturing organization with Merck & Co. Inc. and president of the Drug, Chemical and Associated Technologies Association (DCAT).
The European Commission and Medicines Agency seem to be moving in advance of their ICH partners to update standards.
A look at manufacturing products in process control.
The authors discuss how their research will help FDA in its identification of areas of emphasis in pre- and postapproval evaluation of products and processes.
Industry executives share insight into the future direction of drug manufacturing and the supply chain. This article contains online bonus material.
The authors conducted an experiment to determine the type of extrusion that provides the best productivity and pellet quality. This article contains online bonus material.
Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
The authors discuss the role of quality-control automation in providing better data, enhanced compliance, and potentially faster release times.
The authors group key actions to consider when conducting a product recall and discuss how to execute them carefully and thoroughly.
Capable of great works, pharma as a whole still yields to the lesser angels of its nature.
Industry executives share insight into the future direction of drug manufacturing and the supply chain.
Developments in RNAi, monoclonal antibodies, and more are boosting the biotech marketplace.
A Q&A with Spectrum Laboratories President Tony MacDonald.
Holding product and supply-chain security to the highest standards is crucial for the future.
The manufacture of orally dissolving films is done by various methods such as solvent casting, hot-melt extrusion, semisolid casting, solid-dispersion extrusion, and rolling. The authors discuss these methods and the various parameters in which dissolving films are evaluated.
Poor organization makes it hard for readers to find the helpful information in a recent book.
Industry experts offer their best practices for dealing with deviations. This article contains online bonus material.
CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Analysis of crospovidone as a superdistingrant.
AstraZeneca and Abbott End Program; PhRMA Elects New Members; and More.
Dr. Reddy's Laboratories (Hyderabad, Andhra Pradesh, India) has entered into a technology transfer, manufacturing, and marketing agreement with R-Pharm (Moscow), a Russian pharmaceutical company.
After five years of discussions, the US Food and Drug Administration is joining the Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Cooperation Scheme (PIC Scheme), known together as PIC/S.
The European Medicines Agency launched on December 20, 2010, a public registry about small and medium-sized enterprises (SME) that includes information about SME-registered companies.
Novartis (Basel) signed a memorandum of understanding with the City of St. Petersburg, Russia, confirming its intent to build a new full-scale pharmaceutical manufacturing plant in St. Petersburg.
Pfizer Recalls One Lipitor Lot; Sanofi Aventis Names Head of R&D; and More.
